Allan E. Kamensky - Feb 7, 2022 Form 4 Insider Report for SYNOVUS FINANCIAL CORP (SNV)

Signature
/s/ Mary Maurice Young
Stock symbol
SNV
Transactions as of
Feb 7, 2022
Transactions value $
-$16,291
Form type
4
Date filed
2/9/2022, 03:48 PM
Previous filing
Feb 1, 2022
Next filing
Feb 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNV Common Stock Award $22.9K +448 +0.48% $51.07 92.8K Feb 7, 2022 Direct F1
transaction SNV Common Stock Disposed to Issuer $0 -5.42K -5.83% $0.00 87.4K Feb 7, 2022 Direct F2
transaction SNV Common Stock Tax liability -$39.2K -767 -0.88% $51.07 86.7K Feb 7, 2022 Direct F3
holding SNV Common Stock 5.75K Feb 7, 2022 By Wife
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 7, 2019, the reporting person received a grant of market restricted with a service-based component as well as a Total Shareholder Return Multiplier (the "2019 MRSUs"). These 2019 MRSUs were included on the Form 3 filed on February 1, 2022 by the reporting person (the "Form 3"). On February 7, 2022, pursuant to the terms of the service-based vesting component of the 2019 MRSUs, the third tranche of such award vested. Based upon the Total Shareholder Return Multiplier, the reporting person received 268 additional shares of the Company's restricted stock, such shares representing the amount vested in excess of the target amount of 2019 MRSUs initially included on the Form 3. In addition, the reporting person received 180 shares of the Company's restricted stock through the accrual of dividend equivalents.
F2 On February 7, 2019, the reporting person received a grant of performance stock units (the "PSUs") with a service-based vesting component as well as a performance vesting requirement. These PSUs were included on the Form 3. While the reporting person has satisfied the service-based vesting requirement, the actual amount of PSUs which vested on February 7, 2022 was 0% of the target amount based upon the results of two performance measures during the performance period compared to the performance formula approved by the Compensation and Human Capital Committee of Synovus' Board of Directors. As such, the reporting person received 5,416 less shares (which includes the award plus dividend equivalent rights on those underlying shares) than initially included on the Form 3.
F3 These shares were withheld upon the vesting of 2019 MRSUs to pay tax withholding obligations.